Published in

Elsevier, The Lancet, 10008(386), p. 2059-2068, 2015

DOI: 10.1016/s0140-6736(15)00257-3

Links

Tools

Export citation

Search in Google Scholar

Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): A randomised, double-blind, crossover trial

Journal article published in 2015 by Bryan Williams ORCID, Thomas M. MacDonald, Steve Morant, David J. Webb, Prof Peter Sever, Gordon McInnes, Ian Ford, J. Kennedy Cruickshank, J. Kennedy Cruickshank, Mark J. Caulfield, Jackie Salsbury, Isla Mackenzie, Sandosh Padmanabhan, Morris J. Brown
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO